Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
The Cancer Letter's weekly podcast of interviews, discussions, and more to dig deep into the issues that shape oncology.
New episodes every Wednesday.
SUBSCRIBE ON
Spotify Apple Podcast YouTube
Spotify Apple Podcast YouTube
on air
Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement
Podcast

Breaking down Operation Trailblazer: Rolling INDs, outside expert submission help, and one-trial requirement

July 01, 2026
The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
PodcastThe Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

June 26, 2026
Vol.52 No.25
By Paul Goldberg and Claire Marie Porter
Policy by way of podcaster—FDA issues priority vouchers after Joe Rogan episode on psychedelics
Podcast

Policy by way of podcaster—FDA issues priority vouchers after Joe Rogan episode on psychedelics

June 24, 2026
Peter F. Garrett to people with cancer: Your story has power
Podcast

Peter F. Garrett to people with cancer: Your story has power

June 17, 2026
Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
Podcast

Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science

June 10, 2026
Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes
Podcast

Daraxonrasib’s success in treating pancreatic cancer is a reminder that clinical cancer researchers are heroes

June 03, 2026
The Directors: NCORP PIs discuss workforce shortages, expanding workload, and crushing burden of regulatory oversight
PodcastThe Directors

The Directors: NCORP PIs discuss workforce shortages, expanding workload, and crushing burden of regulatory oversight

May 29, 2026
Vol.52 No.21
By Paul Goldberg and Claire Marie Porter
As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon
Podcast

As FDA’s wheels almost entirely come off, NCI remains sturdy—a cancer moonshot may even be on the horizon

May 27, 2026
The Cancer History Project debuts first de novo book; meanwhile, FDA snafus continue
Podcast

The Cancer History Project debuts first de novo book; meanwhile, FDA snafus continue

May 20, 2026
“Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
Cancer History ProjectFreePodcast

“Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process

May 15, 2026
Vol.52 No.19
By Claire Marie Porter

Posts navigation

123…10Next

Trending Stories

  • Joe Fraumeni, founder of molecular epidemiology, dies at 93
    “It’s hard to imagine a world without the presence of this gentle scientific giant.”
  • Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
  • The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
    “Institutions are feeling crunched in so many different directions”
  • Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
  • Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital
  • To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account